Eyenovia, Inc. Announces Proposed Public Offering
August 20, 2024 17:09 ET
|
Eyenovia, Inc.
NEW YORK, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (“Eyenovia” or the “Company”) (NASDAQ: EYEN), a commercial-stage ophthalmic company, announced today that it intends to offer and sell...
New Horizon Aircraft Announces Pricing of $2.9 Million Public Offering
August 20, 2024 06:00 ET
|
New Horizon Aircraft Ltd.
TORONTO, Aug. 20, 2024 (GLOBE NEWSWIRE) -- New Horizon Aircraft (NASDAQ: HOVR), doing business as Horizon Aircraft (“Horizon Aircraft” or the “Company”), an advanced aerospace engineering company...
HCM II Acquisition Corp. Announces Closing of $230,000,000 Initial Public Offering
August 19, 2024 16:56 ET
|
HCM II Acquisition Corp
STAMFORD, Conn., Aug. 19, 2024 (GLOBE NEWSWIRE) -- HCM II Acquisition Corp. (Nasdaq: HONDU) (the “Company”), announced today the closing of its previously announced initial public offering of...
YXT.com Group Holding Limited Announces Pricing of Initial Public Offering
August 16, 2024 08:13 ET
|
YXT.COM GROUP HOLDING LIMITED
SUZHOU, China, Aug. 16, 2024 (GLOBE NEWSWIRE) -- YXT.com Group Holding Limited (“YXT.com” or the “Company”), a leader and disruptor of the digital corporate learning industry in China, today...
HCM II Acquisition Corp Announces Pricing of $200 Million Initial Public Offering
August 15, 2024 17:50 ET
|
HCM II Acquisition Corp
STAMFORD, Conn., Aug. 15, 2024 (GLOBE NEWSWIRE) -- HCM II Acquisition Corp (the “Company”) announced today the pricing of its initial public offering of 20,000,000 units. The units are expected to...
Mawson Finland Closes IPO and Announces Listing on TSXV
August 15, 2024 16:10 ET
|
Mawson Finland Limited
Not for distribution to United States newswire services or for dissemination in the United States. TORONTO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Mawson Finland Limited (“Mawson” or the “Company”)...
Actuate Therapeutics Announces Closing of Initial Public Offering
August 14, 2024 16:05 ET
|
Actuate Therapeutics
CHICAGO and FORT WORTH, Texas, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (Nasdaq: ACTU) (the “Company”), a clinical stage biopharmaceutical company focused on developing therapies...
Actuate Therapeutics Announces Pricing of Initial Public Offering
August 12, 2024 20:27 ET
|
Actuate Therapeutics
CHICAGO and FORT WORTH, Texas, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (Nasdaq: ACTU) (the “Company”), a clinical stage biopharmaceutical company focused on developing therapies...
Voyager Acquisition Corp. Announces Closing of $253,000,000 Initial Public Offering
August 12, 2024 16:23 ET
|
Voyager Acquisition Corp.
BROOKLYN, N.Y., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Voyager Acquisition Corp. (Nasdaq: VACHU) (the “Company”) today announced that it closed its initial public offering of 25,300,000 units at $10.00...
Voyager Acquisition Corp. Announces Pricing of $220,000,000 Initial Public Offering
August 08, 2024 22:24 ET
|
Voyager Acquisition Corp.
BROOKLYN, N.Y., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Voyager Acquisition Corp. (Nasdaq: VACHU) (the “Company”) announced today the pricing of its initial public offering of 22,000,000 units at $10.00...